Protein A Resin Market Analysis, Share, Drivers, Growth 2024-2033: Strategic Examination

The Protein A Resin by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Protein A Resin Market:

https://www.thebusinessresearchcompany.com/report/protein-a-resin-global-market-report

According to The Business Research Company’s Protein A Resin, The protein a resin market size has grown strongly in recent years. It will grow from $1.53 billion in 2023 to $1.67 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to increasing biopharmaceutical production, growing adoption of monoclonal antibodies, expanding research and development activities, regulatory emphasis on biopharmaceutical quality, rising prevalence of chronic diseases.

The protein a resin market size is expected to see strong growth in the next few years. It will grow to $2.37 billion in 2028 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to rising biosimilar development, focus on cost-efficiency, increasing investment in bioprocessing facilities, expansion of biopharmaceutical market in emerging economies, growing demand for personalized medicine. Major trends in the forecast period include single-use systems, technological advancements, demand in emerging markets, strategic collaborations and partnerships, focus on sustainable practices.

The increased R&D investments in pharmaceutical companies are expected to propel the growth of the protein A resin market forward. R&D refers to the process of researching and developing new drugs, therapies, technologies, or services that can be used to improve the health of patients. Protein A resin is used in several chromatography assays that are used in pharmaceutical development procedures as a chromatography medium. For instance, in 2022, Roche Holding AG, a Switzerland-based pharmaceuticals company spent the highest ever $16.79 billion on R&D which was an increase of 3.7% from 2021. Additionally, in 2022, Merck, a US-based pharmaceuticals company increased its R&D spending by 10% as compared to 2021, Merck spent $13.54 billion on R&D in 2022. As a result, the increased R&D investments in pharmaceutical companies is propelling the growth of the protein A resin market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=9919&type=smp

The protein a resin market covered in this report is segmented –

1) By Type: Natural Protein A, Recombinant Protein A

2) By Matrix Type: Agarose-Based Protein A, Glass/Silica-Based Protein A, Organic Polymer-Based Protein A

3) By Application: Antibody Purification, Immunoprecipitation

4) By End User: Biopharmaceutical Manufacturers, Clinical Research Laboratories, Academic Institutes

Product innovations are a key trend gaining popularity in the protein A resin market. Major companies in the protein A resin market are introducing innovative solutions to sustain their position in the market. For instance, in February 2021, Repligen Corporation, a US-based developer of materials used in manufacturing biological drugs, launched NGL COVID-19 Spike Protein Affinity Resin in partnership with Navigo Proteins GmbH, a Germany-based biotechnology company. The uniqueness of the product is that it is a novel protein A resin that can be used for several vaccines for COVID-19 treatment.

The protein a resin market report table of contents includes: